Correction by Chakravarti, Sumone et al.
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On page 443, the primer sequences for quantitative analysis of Tim-2 expression are incorrect. The corrected sequences are as follows:
Forward primer: 5
 
 
 
-CCTCTACTTCTCCAACACCAGCA-3
 
 
 
Reverse primer: 5
 
 
 
-CCTCAGCTGTAGTCTGATCTGGATAA-3
 
 
 
FAM probe: 5
 
 
 
-ACACAGAGACCTACAAACCAGAGGCCACTACA-3
 
 
 
.
In addition, in Fig. 5 B the data for the hIgG-treated control group of mice were incorrect. The corrected figure and legend appear below.
Figure 5. (B) SJL/J mice were immunized for the induction of EAE
with PLP 139–151 emulsified in CFA, and treated with only one
injection on day 8 with either Tim-2 Ig ( ) or hIgG ( ). Mice were
examined daily for signs of EAE. Mice treated with Tim-2Ig demon-
strated significantly lower (P   0.01) cumulative disease scores when
compared with PBS and hIgG controls.
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